Reccurent stroke revealing catastrophic antiphospholipid syndrome with hepatitis C viral infection;Accidents vasculaires cérébraux révélant un syndrome catastrophique des anti-phospholipides associé à une hépatite virale C

Revue Neurologique

Volumn 162, Issue 11, 2006, Pages 1131-1134

  Rafai, M A ^a   Fadel, H ^a   Gam, I ^a   Hakim, K ^a   El Moutawakkil, B ^a   Kissani, N ^a   Slassi, I ^a  

^a Laboratoire de microbiologie   (Morocco)

Author keywords

Antiphospholipid antibodiy; Catastrophic antiphospholipid syndrom; Hepatitis C viral infection; Stroke

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; FEMALE; HEPATITIS C VIRUS; HUMAN; STROKE; TERMINAL DISEASE; VIRUS INFECTION;

EID: 33750733570     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75128-1     Document Type: Article

References (18)

1. ALARCON-SEGOVIA D, PEREZ-VAZQUEZ ME, VILLA AR, DRENKARD C, CABIEDES J. (1992). Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum, 21: 275-286.
2. AL-SAEED A, MAKRIS M, MALIA RG, PRESTON FE, GREAVES M. (1994). The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Haematol, 88: 845-848.
3. ALRIC L, OSKMAN F, SANMARCO M, IZOPET J, BONNET E, GARCIA-RICART F, VINEL JP, DUFFAUT M. (1997). Association of antiphospholipid syndrome and chronic hepatitis C. Br J Rheumatol, 37: 589-590.
4. ASHERSON RA, CERVERA R, PIETTE JC et al. (1998). Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore), 77: 195-207.
5. BIRON C, ANDREANI H, BLANC P, DUCOS J, LARREY D, MICHEL H, SCHVED JF. (1996). Antiphospholipid antibodies in patients with chronic hepatitis C virus infection or alcoholic liver disease. Preliminary results. Ann Med Interne (Paris), 147 (Suppl 1): 48-49.
6. BREY RL, ESCALANTE A. (1998). Neurological manifestations of antiphospholipid antibody syndrome. Lupus, 7 (Suppl 2): S67-S74.
7. DISDIER P, WEILLER PJ. (1998). Antiphospholipid antibodies syndrome. Rev Prat, 48: 626-631.
8. HACHULLA E, LEYS D, DELEUME JF, PRUVO JP, DEVULDER B. (1995). Neurologic manifestations associated with antiphospholipid antibodies. Or what remains of neurolupus? Rev Med Interne, 16: 121-130.
9. KALASHNIKOVA LA, KORCZYN AD, SHAVIT S, REBROVA O, RESHETNYAK T, CHAPMAN J. (1999). Antibodies to prothrombin in patients with Sneddon's syndrome. Neurology, 53: 223-225.
10. LEROY V, ARVIEUX J, JACOB MC, MAYNARD-MUET M, BAUD M, ZARSKI JP. (1998). Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol, 101: 468-474.
11. LEVINE SR, BREY RL. (1996). Neurological aspects of antiphospholipid antibody syndrome. Lupus, 5: 347-353.
12. MALNICK SD, ABEND Y, EVRON E, STHOEGER ZM. (1997). HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Responseto interferon therapy. J Clin Gastroenterol, 24: 40-42.
13. MUNOZ-RODRIGUEZ FJ, TASSIES D, FONT J et al. (1999). Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol, 30: 770-773.
14. ORDI-ROS J, VILLARREAL J, MONEGAL F, SAULEDA S, ESTEBAN I, VILARDELL M. (2000). Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol, 7: 241-244.
15. PIETTE JC, AMOURA Z, WECHSLER B, FRANCES C. (1998). Neurological manifestations of antiphospholipid syndrome. Rev Med Interne, 19 (Suppl 1): 39S-45S.
16. PRIETO J, YUSTE JR, BELOQUI O, CIVEIRA MP, RIEZU JI, AGUIRRE B, SANGRO B. (1996). Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology, 23: 199-204.
17. RAMOS-CASALS M, CERVERA R, LAGRUTTA M et al., for the Hispanoamerican Study Group of Autoimmune Manifestations of Chronic Viral Disease (HISPAMEC). (2004). Clinical Features Related to AntiphospholipidSyndrome in Patients with Chronic ViralInfections (Hepatitis C Virus/HIV Infection): Description of 82 Cases. Clinical Infectious Diseases, 38: 1009-1016.
18. ZIPOREN L, SHOENFELD Y, LEVY Y, KORCZYN AD. (1997). Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest, 100: 613-619.